Member Info for MasksNewNorm

Strong backing to succeed watch this.

https://youtu.be/gMH7M3zff54

Perfect bounce. Very strong appetite for AMGO. Watched the interview today. Very promising with very strong support to ensure Amigo succeeds. https://youtu.be/gMH7M3zff54

On the revamped Paraytec Home page the Covid-19 test is top of the list, I dont think they would do that if they thought it might fail. Also prominently displayed is the fact that Paraytec is wholly owned by.....Braveheart Investments!
https://www.paraytec.com/

Cant wait. Wouldn’t like to be the obvious ones burning with their short pulled down here.

Great day guys. Market waking up.

Good reversal today. 100p test tomorrow.

Chomp chomp buying as I can.

I only found out about this success today. Just goes to show news does not spread across the whole market fast.

I like that this test can test hundreds of people at once and identify precisely who has an infection. Ideal for large events and gathering from sporting events, theatres to Aircraft passengers.

NT at 77 now trying to get more.

Allowing buys on the tick up. Yum yum

NT to buy. Frustrating.

Identifies bacterial sepsis also. Wonder tech

It’s a real thing then not just p&d bs.

Massive tech for reliable rapid covid and other virus testing for potential further pandemics. Blood clever stuff.

Quite feasible as the cap is only £25m currently.

Another special dividend ???

Paying 79. Still NT to buy

Asking 74 to buy but still NT

Nt to buy now ffs

The current gold standard for estimation of viral load continues to be laboratory-based PCR tests, but these detect viral RNA levels and not necessarily the presence of infectious virions, which means that many patients test positive long after they are no longer infectious.

The AIM-listed firm noted that Paraytec has thus adopted an additional comparator test developed by the University of Sheffield to verify the presence of intact virus particles.

This involves ultracentrifugation and high-resolution fluorescence microscopy to independently verify the presence of virions in clinical samples.

In parallel to the sample processing described above, the Paraytec team has been using isolated lab-grown virus to optimise the operational sensitivity of its instrument for the detection of pre-symptomatic and early-stage symptomatic virus levels.

Wow